Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)

Veronika Ehrlich,Wieneke Bil,Rob Vandebriel,Berit Granum,Mirjam Luijten,Birgitte Lindeman,Philippe Grandjean,Andreas-Marius Kaiser,Ingrid Hauzenberger,Christina Hartmann,Claudia Gundacker and Maria Uhl
DOI: https://doi.org/10.1186/s12940-022-00958-5
2023-02-23
Environmental Health: A Global Access Science Source
Abstract:Per- and polyfluoroalkyl substances (PFAS) are of public health concern, because of their ubiquitous and extremely persistent occurrence, and depending on their structure, their bio-accumulative, mobile and toxic properties. Human health effects associated with exposure to PFAS include adverse effects on the immune system. In 2020, EFSA (the European Food Safety Authority) defined adverse effects on the immune system as the most critical effect for human health risk assessment, based on reduced antibody responses to childhood vaccines and similar effects observed in experimental animal studies. Likewise, the U.S. EPA (Environmental Protection Agency) considers PFAS-induced immunotoxicity, especially in children, as the critical effect for risk assessment. However, the mechanisms by which antibody concentrations are impacted are not completely understood. Furthermore, other targets of the immune system functions have been reported in the literature.
What problem does this paper attempt to address?